These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23228121)

  • 21. Update on the use of cinacalcet in the management of primary hyperparathyroidism.
    Marcocci C; Cetani F
    J Endocrinol Invest; 2012 Jan; 35(1):90-5. PubMed ID: 22104762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative hypocalcemia after parathyroidectomy for renal hyperparathyroidism in the era of cinacalcet.
    Meyers MO; Russell CP; Ollila DW; Yeh JJ; Kim HJ; Calvo BF
    Am Surg; 2009 Sep; 75(9):843-7. PubMed ID: 19774959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with cinacalcet in 29 kidney transplant patients with persistent hyperparathyroidism.
    López V; Toledo R; Sola E; Gutiérrez C; Sujan S; Rodríguez MA; Cabello M; Burgos D; González Molina M; Hernández D
    Transplant Proc; 2009; 41(6):2394-5. PubMed ID: 19715930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A step towards cinacalcet testing for the diagnosis of primary hyperparathyroidism: comparison with the standardized intravenous calcium loading. A pilot study.
    Cailleux A; Vuillermet P; Basuyau JP; Ménard JF; Lefebvre H; Kuhn JM; Prévost G
    Clin Endocrinol (Oxf); 2015 May; 82(5):663-9. PubMed ID: 25645432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New strategies for the treatment of hyperparathyroidism incorporating calcimimetics.
    de Francisco AL
    Expert Opin Pharmacother; 2008 Apr; 9(5):795-811. PubMed ID: 18345956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.
    Dong BJ
    Clin Ther; 2005 Nov; 27(11):1725-51. PubMed ID: 16368445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
    Khan A; Grey A; Shoback D
    J Clin Endocrinol Metab; 2009 Feb; 94(2):373-81. PubMed ID: 19193912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic challenges in elderly patients with symptomatic hypercalcaemia caused by primary hyperparathyroidism.
    Jacobs L; Samson MM; Verhaar HJ; Koek HL
    Neth J Med; 2012 Jan; 70(1):35-8. PubMed ID: 22271812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cinacalcet HCl suppresses Cyclin D1 oncogene-derived parathyroid cell proliferation in a murine model for primary hyperparathyroidism.
    Imanishi Y; Kawata T; Kenko T; Wada M; Nagano N; Miki T; Arnold A; Inaba M
    Calcif Tissue Int; 2011 Jul; 89(1):29-35. PubMed ID: 21541686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet.
    Falchetti A; Cilotti A; Vaggelli L; Masi L; Amedei A; Cioppi F; Tonelli F; Brandi ML
    Nat Clin Pract Endocrinol Metab; 2008 Jun; 4(6):351-7. PubMed ID: 18414463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and safety of cinacalcet for primary hyperparathyroidism: a single center experience.
    Manaka K; Sato J; Kinoshita Y; Ito N; Fujita M; Iiri T; Nangaku M; Makita N
    Endocr J; 2019 Aug; 66(8):683-689. PubMed ID: 31092749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis.
    Narayan R; Perkins RM; Berbano EP; Yuan CM; Neff RT; Sawyers ES; Yeo FE; Vidal-Trecan GM; Abbott KC
    Am J Kidney Dis; 2007 Jun; 49(6):801-13. PubMed ID: 17533023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism.
    Kruse AE; Eisenberger U; Frey FJ; Mohaupt MG
    Nephrol Dial Transplant; 2007 Aug; 22(8):2362-5. PubMed ID: 17510094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent elevation in serum parathyroid hormone levels in normocalcemic patients after parathyroidectomy: does it matter?
    Carsello CB; Yen TW; Wang TS
    Surgery; 2012 Oct; 152(4):575-81; discussion 581-3. PubMed ID: 23021134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.
    Moe SM; Cunningham J; Bommer J; Adler S; Rosansky SJ; Urena-Torres P; Albizem MB; Guo MD; Zani VJ; Goodman WG; Sprague SM
    Nephrol Dial Transplant; 2005 Oct; 20(10):2186-93. PubMed ID: 16030053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcimimetics versus parathyroidectomy for treatment of primary hyperparathyroidism: retrospective chart analysis of a prospective database.
    Keutgen XM; Buitrago D; Filicori F; Kundel A; Elemento O; Fahey TJ; Zarnegar R
    Ann Surg; 2012 May; 255(5):981-5. PubMed ID: 22470074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose.
    Kamar N; Gennero I; Spataru L; Esposito L; Guitard J; Lavayssière L; Cointault O; Gandia P; Durand D; Rostaing L
    Nephrol Dial Transplant; 2008 Nov; 23(11):3720-6. PubMed ID: 18558623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal.
    Paschoalin RP; Torregrosa JV; Barros X; Durán CE; Campistol JM
    Transplant Proc; 2012 Oct; 44(8):2376-8. PubMed ID: 23026597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anaemia and marrow fibrosis in patients with primary hyperparathyroidism before and after curative parathyroidectomy.
    Bhadada SK; Bhansali A; Ahluwalia J; Chanukya GV; Behera A; Dutta P
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):527-32. PubMed ID: 18727711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects.
    Duntas LH; Stathatos N
    Endocrine; 2011 Jun; 39(3):199-204. PubMed ID: 21442382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.